410 related articles for article (PubMed ID: 18978467)
21. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
[TBL] [Abstract][Full Text] [Related]
22. STAT3 mutations in the hyper-IgE syndrome.
Holland SM; DeLeo FR; Elloumi HZ; Hsu AP; Uzel G; Brodsky N; Freeman AF; Demidowich A; Davis J; Turner ML; Anderson VL; Darnell DN; Welch PA; Kuhns DB; Frucht DM; Malech HL; Gallin JI; Kobayashi SD; Whitney AR; Voyich JM; Musser JM; Woellner C; Schäffer AA; Puck JM; Grimbacher B
N Engl J Med; 2007 Oct; 357(16):1608-19. PubMed ID: 17881745
[TBL] [Abstract][Full Text] [Related]
23. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
[TBL] [Abstract][Full Text] [Related]
24. The hyper-IgE syndromes.
Freeman AF; Holland SM
Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333
[TBL] [Abstract][Full Text] [Related]
25. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
26. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestations of hyper IgE syndromes.
Freeman AF; Holland SM
Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
[TBL] [Abstract][Full Text] [Related]
28. An update on the hyper-IgE syndromes.
Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
[TBL] [Abstract][Full Text] [Related]
29. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
30. Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care.
Farmand S; Sundin M
Curr Opin Hematol; 2015 Jan; 22(1):12-22. PubMed ID: 25469836
[TBL] [Abstract][Full Text] [Related]
31. Primary Immunodeficiencies with Elevated IgE.
Mogensen TH
Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
[TBL] [Abstract][Full Text] [Related]
32. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
[TBL] [Abstract][Full Text] [Related]
33. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
[TBL] [Abstract][Full Text] [Related]
34. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
35. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
36. [STAT3 mutation in a child with hyper-IgE syndrome and incomplete clinical features].
Szaflarska A; Rutkowska-Zapała M; Pituch-Noworolska A; Siedlar M
Przegl Lek; 2015; 72(12):787-90. PubMed ID: 27024962
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohort.
Alcántara-Montiel JC; Staines-Boone T; López-Herrera G; Espinosa-Rosales F; Espinosa-Padilla SE; Hernández-Rivas R; Santos-Argumedo L
Clin Genet; 2016 Feb; 89(2):217-21. PubMed ID: 26293184
[TBL] [Abstract][Full Text] [Related]
38. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
[TBL] [Abstract][Full Text] [Related]
39. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]